These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 12903650)

  • 1. Challenges of designing hepatic encephalopathy treatment trials.
    Sanaka MR; Ong JP; Mullen KD
    Hepatology; 2003 Aug; 38(2):527-8. PubMed ID: 12903650
    [No Abstract]   [Full Text] [Related]  

  • 2. L-Ornithine-l-aspartate in the management of hepatic encephalopathy: a meta-analysis.
    Jiang Q; Jiang XH; Zheng MH; Chen YP
    J Gastroenterol Hepatol; 2009 Jan; 24(1):9-14. PubMed ID: 18823442
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antibiotics in the management of hepatic encephalopathy: an evidence-based review.
    Rothenberg ME; Keeffe EB
    Rev Gastroenterol Disord; 2005; 5 Suppl 3():26-35. PubMed ID: 17713457
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Review of the final report of the 1998 Working Party on definition, nomenclature and diagnosis of hepatic encephalopathy.
    Mullen KD
    Aliment Pharmacol Ther; 2007 Feb; 25 Suppl 1():11-6. PubMed ID: 17295847
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Management of hepatic encephalopathy in patients with cirrhosis.
    Wright G; Jalan R
    Best Pract Res Clin Gastroenterol; 2007; 21(1):95-110. PubMed ID: 17223499
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of antibiotics in the management of hepatic encephalopathy.
    Maddrey WC
    Rev Gastroenterol Disord; 2005; 5 Suppl 1():S3-9. PubMed ID: 15976746
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Disruption of smooth pursuit eye movements in cirrhosis: relationship to hepatic encephalopathy and its treatment.
    Montagnese S; Gordon HM; Jackson C; Smith J; Tognella P; Jethwa N; Sherratt RM; Morgan MY
    Hepatology; 2005 Oct; 42(4):772-81. PubMed ID: 16175619
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [A clinical observation on therapeutic effect of colon purification on hepatic encephalopathy].
    Zhao HP; Ding BH; Zhang JS; Guo SM; Zhang ZR; Zhao YZ
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2008 Jun; 22(3):222-4. PubMed ID: 19031710
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of treatment with the Molecular Adsorbents Recirculating System on arterial amino acid levels and cerebral amino acid metabolism in patients with hepatic encephalopathy.
    Schmidt LE; Tofteng F; Strauss GI; Larsen FS
    Scand J Gastroenterol; 2004 Oct; 39(10):974-80. PubMed ID: 15513337
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Normal protein diet for episodic hepatic encephalopathy: results of a randomized study.
    Córdoba J; López-Hellín J; Planas M; Sabín P; Sanpedro F; Castro F; Esteban R; Guardia J
    J Hepatol; 2004 Jul; 41(1):38-43. PubMed ID: 15246205
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Confusion and abnormal liver enzyme levels: problems with diagnosing hepatic encephalopathy].
    Hendriks ME; van Westerloo DJ; Portegies P
    Ned Tijdschr Geneeskd; 2007 Dec; 151(49):2701-6. PubMed ID: 18225787
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatic encephalopathy: pathophysiology and advances in therapy.
    Av SP
    Trop Gastroenterol; 2007; 28(1):4-10. PubMed ID: 17896602
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Complex therapy of chronic hepatic encephalopathy supplemented with probiotic: comparison of two studies].
    Boca M; Vyskocil M; Mikulecký M; Ebringer L; Kolibás E; Kratochvíl'ová H; Buzgová D
    Cas Lek Cesk; 2004; 143(5):324-8. PubMed ID: 15305769
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phospholipid and cholesterol alterations accompany structural disarray in myelin membrane of rats with hepatic encephalopathy induced by thioacetamide.
    Swapna I; Kumar KV; Reddy PV; Murthy ChR; Reddanna P; Senthilkumaran B
    Neurochem Int; 2006 Aug; 49(3):238-44. PubMed ID: 16519962
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evidence against a role for endotoxin in the hepatic encephalopathy of rats with thioacetamide-induced fulminant hepatic failure.
    Chen CT; Chu CJ; Wang TF; Lu RH; Lee FY; Chang FY; Lin HC; Chan CC; Wang SS; Huang HC; Lee SD
    J Gastroenterol Hepatol; 2005 Mar; 20(3):450-5. PubMed ID: 15740491
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neuroinflammation contributes to hypokinesia in rats with hepatic encephalopathy: ibuprofen restores its motor activity.
    Cauli O; Rodrigo R; Piedrafita B; Llansola M; Mansouri MT; Felipo V
    J Neurosci Res; 2009 May; 87(6):1369-74. PubMed ID: 19025766
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of portal systemic encephalopathy: standard and new treatments.
    Marín E; Uribe M
    Rev Invest Clin; 1990 Jul; 42 Suppl():141-8. PubMed ID: 19256154
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Nonabsorbable disaccharides for the treatment of hepatic encephalopathy--a systemic review of randomized clinical trials--a secondary publication].
    Als-Nielsen BE; Gluud LL; Gluud CN
    Ugeskr Laeger; 2005 Jan; 167(2):179-82. PubMed ID: 15697132
    [No Abstract]   [Full Text] [Related]  

  • 19. Malnutrition and hypermetabolism are not risk factors for the presence of hepatic encephalopathy: a cross-sectional study.
    Sörös P; Böttcher J; Weissenborn K; Selberg O; Müller MJ
    J Gastroenterol Hepatol; 2008 Apr; 23(4):606-10. PubMed ID: 18005013
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Minimal hepatic encephalopathy: time to recognise and treat.
    Dhiman RK; Chawla YK
    Trop Gastroenterol; 2008; 29(1):6-12. PubMed ID: 18564660
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.